Difficulty: Medium
Average Score: 93%
Practice
A 25-year-old G1P0 woman presents to the emergency department with shaking chills, chest pain, and productive cough. A chest X-ray reveals an area of opacity in the right lower lobe. The physician's choice of antibiotics is limited because some may harm this patient's fetus. Which of the following antibiotics may cause hearing loss in her fetus?
Correct answer
D
Rationale
The correct answer is D) Streptomycin. Streptomycin belongs to the aminoglycoside class of antibiotics, which are known to have ototoxicity potential and can cause irreversible hearing loss in the fetus if taken during pregnancy. This is due to the drug's ability to cross the placental barrier and affect the developing fetal auditory system.
A) Amoxicillin is a penicillin antibiotic and is considered safe for use during pregnancy as it does not pose a significant risk of harm to the fetus.
B) Ciprofloxacin is a fluoroquinolone antibiotic that has been associated with cartilage abnormalities in developing animals but has not been definitively linked to hearing loss in human fetuses.
C) Erythromycin is a macrolide antibiotic that is generally considered safe for use during pregnancy and does not have known ototoxic effects on the fetus.
In an educational context, understanding the potential adverse effects of medications during pregnancy is crucial for healthcare providers, especially when treating pregnant women or women of childbearing age. Knowledge of which drugs can harm the fetus helps in making informed decisions to ensure the safety and well-being of both the mother and the developing baby. Healthcare professionals must be aware of the risks associated with certain medications to provide optimal care to pregnant patients.
A) Amoxicillin is a penicillin antibiotic and is considered safe for use during pregnancy as it does not pose a significant risk of harm to the fetus.
B) Ciprofloxacin is a fluoroquinolone antibiotic that has been associated with cartilage abnormalities in developing animals but has not been definitively linked to hearing loss in human fetuses.
C) Erythromycin is a macrolide antibiotic that is generally considered safe for use during pregnancy and does not have known ototoxic effects on the fetus.
In an educational context, understanding the potential adverse effects of medications during pregnancy is crucial for healthcare providers, especially when treating pregnant women or women of childbearing age. Knowledge of which drugs can harm the fetus helps in making informed decisions to ensure the safety and well-being of both the mother and the developing baby. Healthcare professionals must be aware of the risks associated with certain medications to provide optimal care to pregnant patients.